A batch of COVID-19 vaccines – 698,500 doses of COVISHIELD, the Indian analogue of AstraZeneca/Oxford vaccine – was delivered from India to Tajikistan yesterday night under the COVAX mechanism with the support from UNICEF.
India was the first country to deliver COVID-19 vaccines – 192,000 doses of COVISHILED – to Tajikistan in March 2021 under the COVAX mechanism.
COVISHIELD, manufactured by SIIPL was assessed under the WHO EUL procedure based on the review of data on quality, safety, efficacy, risk management plan (RMP) and programmatic suitability performed by WHO Vaccine Prequalification experts and evaluators from National Regulatory Authorities (NRAs) from different countries and regions.
Tajikistan began COVID-19 vaccination campaign on March 23, 2021.
According to statistical data from the Ministry of Health and Social Protection of the Population (MoHSPP), 6,137,700 doses of five types of vaccines, including COVISHIELD, China’s CoronaVac, Russia’s Sputnik V and the United States’ Moderna and Pfizer, have been delivered to Tajikistan to date.
As of November 30, 3,206,063 (51.8 percent) people in Tajikistan have received the first dose of the COVID-19 vaccine, with 2,590,545 of them (44.5 percent) having received both doses.
Healthcare is one of the priorities for AKDN in Tajikistan
IMF managing director to pay visit to Tajikistan this week
Former Dushanbe mayor’s son removed from office
Tajikistan to receive a soft loan for construction of the country’s longest bridge
Kazakhstan transfers 100 vouchers for training of IT specialists to Tajikistan
OpenAI introduces GPT-4o, making more capabilities available for free in ChatGPT.
The United States will help Central Asia’s nations find new foreign trade markets
Kazakhstan intensifies scrutiny of labor migrants from Tajikistan
Putin holds a video conference meeting with permanent members of the Russian Security Council
Uzbekistan will supply more than 900 million liters of water to Kazakhstan during the irrigation season
All news
Авторизуйтесь, пожалуйста